Pharmaceutical Contract Sales Organization (CSO) Market Analysis

The study aims to understand the market landscape and usage of different outsourced contract sales organization (CSO) providers by pharmaceutical companies. The primary objective was to explore the experiences of pharmaceutical sales leadership with outsourced CSOs and identify pain points or areas for improvement. The interviews were conducted with participants from Tier 1 or Tier 2 pharmaceutical companies in the US responsible for national sales territories in immunology, oncology, and general medicine therapeutic areas.

Our research team employed a thorough screening process to identify highly knowledgeable experts using our internal platform. Once the experts were vetted and selected, we scheduled one-on-one telephone interviews with the identified respondents. Our team of researchers worked diligently to ensure the study’s success, adhering to best practices in qualitative research methodology and maintaining a high level of professionalism in all interactions with study participants.

The study provided insights into the current market landscape and usage of different CSO providers by pharmaceutical companies. The client gained a deeper understanding of pharmaceutical sales leadership experiences with outsourced CSOs, including their perceptions of benefits and drawbacks. Additionally, the client gained insights into the criteria that pharmaceutical sales leadership use to select CSO providers and their preferences for different providers.